Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.

Antibody testing after COVID-19 vaccination is generally not recommended. Here, we present the results of a retrospective study, in which we analyzed antibody levels before and after the first dose of the ChAdOx1 vector vaccine. We identified 5% non-responders (43.6 ± 10.6 years; females: 41%) and 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Angelika, Ohradanova-Repic, Anna, Gebetsberger, Laura, Tajti, Gabor, Kundi, Michael, Stockinger, Hannes, Wiedermann, Ursula, Grabmeier-Pfistershammer, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of European Federation of Immunological Societies. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468054/
https://www.ncbi.nlm.nih.gov/pubmed/36108774
http://dx.doi.org/10.1016/j.imlet.2022.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468054/
https://www.ncbi.nlm.nih.gov/pubmed/36108774
http://dx.doi.org/10.1016/j.imlet.2022.09.001

Ejemplares similares